Current Cardiovascular Imaging Reports

, Volume 5, Issue 6, pp 390–392 | Cite as

Assessing Myocardial Viability in Patients with Ischemic Left Ventricular Dysfunction

  • Maria Piera Petretta
  • Giovanni Fiumara
  • Renato Cuocolo
  • Mario Petretta
  • Alberto Cuocolo
Invited Commentary


Myocardial viability Coronary artery disease Left ventricular dysfunction 



No potential conflicts of interest relevant to this article were reported.


  1. 1.
    Rahimtoola SH, La Canna G, Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol. 2006;47:978–80.PubMedCrossRefGoogle Scholar
  2. 2.
    Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol. 2006;47:969–77.PubMedCrossRefGoogle Scholar
  3. 3.
    Bonow RO, Maurer G, Lee KL, et al. STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–21.PubMedCrossRefGoogle Scholar
  5. 5.
    Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103–14.PubMedCrossRefGoogle Scholar
  7. 7.
    Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1–e90.PubMedCrossRefGoogle Scholar
  8. 8.
    Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.PubMedCrossRefGoogle Scholar
  9. 9.
    Cleland JG, Calvert M, Freemantle N, et al. The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail. 2011;13:227–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Bourque JM, Velazquez EJ, Tuttle RH, Shaw LK, O’Connor CM, Borges-Neto S. Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings. J Nucl Cardiol. 2007;14:165–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Hachamovitch R, Rozanski A, Hayes SW, et al. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol. 2006;13:768–78.PubMedCrossRefGoogle Scholar
  12. 12.
    Mudrick DW, Velazquez E, Borges-Neto S. Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction? Curr Cardiol Rep. 2010;12:155–61.PubMedCrossRefGoogle Scholar
  13. 13.
    Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375–410.PubMedCrossRefGoogle Scholar
  15. 15.
    Hanekom L, Jenkins C, Jeffries L, et al. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow up study after revascularization. Circulation. 2005;112:3892–900.PubMedCrossRefGoogle Scholar
  16. 16.
    Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:147–86.PubMedCrossRefGoogle Scholar
  18. 18.
    Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease a meta-analysis of prospective trials. JACC Cardiovasc Imaging. 2012;5:494–508.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Maria Piera Petretta
    • 1
  • Giovanni Fiumara
    • 2
  • Renato Cuocolo
    • 1
  • Mario Petretta
    • 3
  • Alberto Cuocolo
    • 1
  1. 1.Department of Biomorphological and Functional SciencesUniversity of Naples Federico IINaplesItaly
  2. 2.SDN FoundationInstitute of Diagnostic and Nuclear DevelopmentNaplesItaly
  3. 3.Department of Clinical Medicine, Cardiovascular and Immunological SciencesUniversity of Naples Federico IINaplesItaly

Personalised recommendations